2m 2m 2m 2m 2m 2m 2m
DYNE THERAPEUTCS (DYN)
NASDAQ
$23.80+$0.16 (+0.68%)
Price as of Jul 14, 2026 4:03 AM EDT- $3.9BMarket Cap
- 165.32%1-Year Change
- BiotechnologyIndustry
DYNE THERAPEUTCS (DYN)
$23.80+$0.16 (+0.68%)
DYN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $23.64 | ||
Change | +$0.22 (+0.94%) | ||
Open | $23.26 | ||
High | $23.77 | ||
Low | $22.63 | ||
Previous Close | $23.42 | ||
Volume | 1,884,700 | ||
30-Day Average Volume | 2,484,617 | ||
1-Week Change | 3.50% | ||
1-Month Change | 29.96% | ||
1-Year Change | 165.32% | ||
3-Year Change | 106.28% | ||
5-Year Change | 19.39% | ||
Fundamentals | |||
Shares Outstanding | 165.3M | ||
Total Assets | $1.1B | ||
Market Cap | $3.9B | ||
Enterprise Value | $3.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$120.9M | ||
Free Cash Flow | -$145.1M | ||
EBIT | -$116.7M | ||
EBITDA | -$116.1M | ||
Net Working Capital | $969.8M | ||
EPS | -$0.73 | ||
Enterprise Value/EBITDA | -28 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -32 | ||
PEG | -9 | ||
Price/Free Cash Flow | -27 | ||
Price/Operating Cash Flow | -27 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue